Needed: Pragmatic Clinical Trials for Statin-Intolerant Patients

被引：64
|
作者：
Maningat, Patricia [1 ]
Breslow, Jan L. [1 ]
机构：
[1] Rockefeller Univ, New York, NY 10021 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 365卷 / 24期
关键词：
D O I：
10.1056/NEJMp1112023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2250 / 2251
页数：2
相关论文
共 50 条
  • [31] Non-traditional Dosing of Statins in Statin-Intolerant Patients-Is It Worth a Try?
    Cornier, Marc-Andre
    Eckel, Robert H.
    CURRENT ATHEROSCLEROSIS REPORTS, 2015, 17 (02)
  • [32] PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
    Casula, Manuela
    Pirillo, Angela
    Norata, Giuseppe Danilo
    Catapano, Alberico Luigi
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (14) : 1525 - 1527
  • [33] REAL WORLD EFFICACY OF BEMPEDOIC ACID IN STATIN-INTOLERANT PATIENTS WITH HIGH CARDIOVASCULAR RISK
    Mccarron, E. P.
    Hamilton, P.
    Roberts, B. V.
    ATHEROSCLEROSIS, 2022, 355 : E302 - E302
  • [34] Statin-Intolerant Patients Exhibit Diminished Muscle Strength Regardless of Lipid-Lowering Therapy
    Vinci, Pierandrea
    Di Girolamo, Filippo Giorgio
    Pellicori, Federica
    Panizon, Emiliano
    Pirulli, Alessia
    Tosoni, Letizia Maria
    Altamura, Nicola
    Rizzo, Stefania
    Perin, Andrea
    Fiotti, Nicola
    Biolo, Gianni
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [35] Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
    Moriarty, Patrick M.
    Thompson, Paul D.
    Cannon, Christopher P.
    Guyton, John R.
    Bergeron, Jean
    Zieve, Franklin J.
    Bruckert, Eric
    Jacobson, Terry A.
    Kopecky, Stephen L.
    Baccara-Dinet, Marie T.
    Du, Yunling
    Pordy, Robert
    Gipe, Daniel A.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2015, 9 (06) : 758 - 769
  • [36] Randomized Trial of Ezetimibe versus Nutraceuticals in Statin-intolerant Patients Treated With Percutaneons Coronary Intervention
    Marazzi, Giuseppe
    Pelliccia, Francesco
    Volterrani, Maurizio
    Righi, Daniela
    Cacciotti, Luca
    Campolongo, Giuseppe
    Sposato, Barbara
    Grieco, Fabrizia
    Pasceri, Vincenzo
    Greco, Cesare
    Rosano, Giuseppe
    Gaudio, Carlo
    CIRCULATION, 2012, 126 (21)
  • [37] Bempedoic acid as treatment for subjects at cardiovascular risk who are statin-intolerant
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (15) : 1673 - 1677
  • [38] Efficacy and Safety of Ezetimibe Plus Orlistat or Rimonabant in Statin-Intolerant Nondiabetic Overweight/Obese Patients With Dyslipidemia
    Florentin, Matilda
    Kostapanos, Michael S.
    Nakou, Eleni S.
    Elisaf, Moses
    Liberopoulos, Evangelos N.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2009, 14 (04) : 274 - 282
  • [39] CLEARING THE ROLE OF BEMPEDOIC ACID FOR DYSLIPIDEMIA IN STATIN-INTOLERANT PATIENTS - A SYSTEMATIC REVIEW AND META-ANALYSIS
    Ternes, Caique M. P.
    Pasqualotto, Eric
    Wippel, Catherine Wegner
    Fernandes, Amanda
    Rivera, Andre
    Braga, Marcelo
    Costa Fernandes Filho, Gilson M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2022 - 2022
  • [40] Rethinking cardiovascular prevention: cost-effective cholesterol lowering for statin-intolerant patients in Australia and the UK
    Morton, Jedidiah, I
    Liew, Danny
    Watts, Gerald F.
    Zoungas, Sophia
    Nicholls, Stephen J.
    Dixon, Padraig
    Ademi, Zanfina
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2025,
12345